SignalSlide ® Phospho-Akt (Ser473) IHC Controls from Cell Signaling Technology

Product Specs
ItemSignalSlide ® Phospho-Akt (Ser473) IHC Controls
CompanyCell Signaling Technology
Price $189.00 Inquire
Catalog Number8101S
Quantity1 Pack
FormatTissue Slide, paraffin section
ModificationsAkt1 (Ser473) phosphate
Research AreaPI3K / Akt Signaling
Source/Expression SystemHuman
ApplicationsIHC

Add to Compare List

Cell Signaling Technology

3 Trask Lane

Danvers, Massachusetts 01923

United States

Phone: 877-616-CELL
Phone: 978-867-2388
Fax: 866-432-6112
Fax: 978-867-2488

Company Profile

Website: http://www.cellsignal.com/

Website: Technical Support

(1) Activation of the Mammalian Target of Rapamycin Pathway in Endothelial Cells in Antiphospholipid Antibody-Positive Patients with Leg UlcersInt J Mol SciMarch 19, 2025András L. Kovács, Csaba Gyömörei, Szabina Horváth, Viktória Németh, Réka Dudley, Zsuzsanna Nagy, Tímea Berki, Zsuzsanna Lengyel, Rolland Gyulaipositive control model developed by the manufacturer (SignalSlide® Phospho-Akt (Ser473) IHC Controls #8101, Cell Signaling Technology/USA) was utilized for the pAKT D9E antibody, diluted in the manufacturer-recommended

(2) Transition from Microstrip Line to Ridge Empty Substrate Integrated Waveguide Based on the Equations of the SuperellipseApplied SciencesNovember 16, 2020David Herraiz, Héctor Esteban, Juan A. Martínez, Angel Belenguer, Santiago Cogollos, Vicente Nova, Vicente E. Boriathey are compared with the cutoff frequencies of an ESIW (no ridge layers). Appl. Sci. 2020, 10, 8101 11 of 13 22 fc20 15 0 layers 1 layer fc10 10 7 0 0.2 0.4 0.6 fc20 20 Frequency (GHz) Frequency

(3) PI3K/Akt/mTOR signalling pathway activation in patients with ER‑positive, metachronous, contralateral breast cancer treated with hormone therapyOncology LettersNovember 26, 2018Hirofumi Kanaizumi, Chihiro Higashi, Yumiko Tanaka, Mika Hamada, Wataru Shinzaki, Tatsuya Azumi, Yukihiko Hashimoto, Hiroki Inui, Toshiya Houjou, Yoshifumi Komoikeand 5‑12: strongly positive (Fig. 1). The positive controls used for staining intensity were IHC controls #8101 for pS6 and #8103 for pMAPK (SignalSlide®; Cell Signaling Technology, Inc.). Immunohistochemical analysis

(4) Suppression of insulin feedback enhances the efficacy of PI3K inhibitorsNatureAugust 1, 2018Hopkins BD, Pauli C, Du X, Wang DG, Li X, Wu D, Amadiume SC, Goncalves MD, Hodakoski C, Lundquist MR, et al.phospho-INSR (Tyr 1162; Thermo Fisher #AHR0271) 1:100; phospho-AKT (Ser473; Cell Signaling Technology, 8101) 1:20; and phospho-S6 ribosomal protein (Ser235/236; Cell Signaling Technology, 2211) 1:300). Blood

(5) Nubbin isoform antagonism governs Drosophila intestinal immune homeostasisPLOS PathogensMarch 2, 2018Bo G. Lindberg, Xiongzhuo Tang, Widad Dantoft, Priya Gohel, Shiva Seyedoleslami Esfahani, Jessica M. Lindvall, Ylva Engström

(6) HDAC9 is an epigenetic repressor of kidney angiotensinogen establishing a sex differenceBiology of Sex DifferencesDecember 1, 2017Camille T. Bourgeois, Ryousuke Satou, Minolfa C. Prieto

(7) Personalized In Vitro and In Vivo Cancer Models to Guide Precision MedicineCancer DiscoveryMay 1, 2017Chantal Pauli et al.Cleaved Caspase-3 (Asp175)(5A1E)(Cell Signaling, 9664) 1:200, Phospho-AKT (Ser473) (Cell Signaling, 8101) 1:20 and Phospho-S6 Ribosomal Protein (Ser235/236) (Cell Signaling, 2211) 1:300. Supplementary Material

(8) Maternal diets deficient in folic acid and related methyl donors modify mechanisms associated with lipid metabolism in the fetal liver of the ratBritish Journal of NutritionNovember 28, 2009Christopher J. McNeil, Susan M. Hay, Garry J. Rucklidge, Martin D. Reid, Gary J. Duncan, William D. Reesmetabolism 6411 3202 4505 3307 2716 2009 4808 4613 6702 Fat metabolism 2104 2302 3206 3501 5203 6109 Cell signalling 3106 8101 1016 3402 2004 Control 2 F, folate-deficient diet; 2F LM LC, folate-deficient diet with low methionine

Be the First to Write a Review!